Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 11/20 | 0.49 |
| ▸ | PI4KA | P42356 | 9/20 | 0.49 |
| ▸ | PIK3CA | P42336 | 9/20 | 0.42 |
| ▸ | MTOR | P42345 | 7/20 | 0.42 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.40 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL807111 | 0.94 | RAB9A (0.46) | PIK3CGPI4KAPIK3CAPIK3CDPIK3CB | |
| SCHEMBL789808 | 0.94 | PIK3CG (0.44) | PIK3CGPI4KAPIK3CAMTORPIK3C3 | |
| SCHEMBL790487 | 0.93 | PIK3CG (0.47) | PIK3CGPI4KAPIK3CAMTORPIK3C3 | |
| SCHEMBL807010 | 0.91 | SMN1; SMN2 (0.44) | PIK3CGPI4KAPIK3CAPIK3C3PIK3CD | |
| SCHEMBL798453 | 0.89 | PIK3CG (0.43) | PIK3CGPI4KAPIK3CAPIK3C3PIK3CD | |
| SCHEMBL790802 | 0.88 | PIK3CG (0.64) | PIK3CGPI4KAPIK3CAMTORPIK3C3 | |
| SCHEMBL806791 | 0.88 | PI4KA (0.43) | PIK3CGPI4KAPIK3CAMTORPIK3C3 | |
| SCHEMBL807247 | 0.88 | PIK3CG (0.48) | PIK3CGPI4KAPIK3CAMTORPIK3C3 | |
| SCHEMBL789741 | 0.87 | PI4KA (0.46) | PIK3CGPI4KAPIK3CAMTORRAB9A | |
| SCHEMBL791568 | 0.86 | PI4KA (0.43) | PIK3CGPI4KAPIK3CAMTORPIK3C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012037108-A1 | AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS | GLAXOSMITHKLINE LLC (US) | 2012-03-22 | — | — | WO | disclosed |